Skip to main content

Table 1 Characteristics of eligible non-diabetic patients aged ≥ 30 years with a known cardiovascular risk factor and impaired fasting glucose level (≥ 110-125 md/dl) by center and comparison group

From: Effectiveness of two procedures for deploying a facilitated collaborative modeling implementation strategy—the PVS-PREDIAPS strategy—to optimize type 2 diabetes prevention in primary care: the PREDIAPS cluster randomized hybrid type II implementation trial

  Global group Sequential group
  PC1
N = 155
PC2
N = 456
PC3
N = 737
PC4
N = 278
Total PC5
N = 228
PC6
N = 253
PC7
N = 665
PC8
N = 303
PC9
N = 188
Total
Age, mean (sd) 65.3 (13.7) 68.3 (12.5) 67.9 (12.2) 69.0 (11.6) 67.9 (12.4) 67.3 (13.5) 68.7 (13.2) 67.6 (13.2) 65.1 (12.4) 66.4 (12.6) 67.1 (13.0)
Women
n (%)
73 (47.1%) 252 (55.3%) 385 (52.2%) 138 (49.6%) 848 (52.1%) 116 (48.7%) 122 (48.2%) 336 (50.5%) 143 (47.2%) 93 (49.5%) 810 (49.2%)
BMI ≥ 25
n (%)
106 (68.4%) 286 (62.7%) 471 (63.9%) 177 (63.4%) 1040 (64.0%) 173 (72.7%) 166 (65.6%) 397 (59.7%) 231 (76.2%) 145 (77.1%) 1112 (67.5%)
BMI ≥ 30
n (%)
65 (41.9%) 190 (41.7%) 272 (36.9%) 101 (36.3%) 628 (38.6%) 114 (47.9%) 105 (41.5%) 230 (34.6%) 145 (47.8%) 94 (50%) 688 (41.8%)
SBP > 140
n (%)
61 (39.3%) 210 (46 %) 376 (51 %) 123 (44.2%) 770 (47.3%) 110 (46.2%) 131 (51.8%) 301 (45.3%) 143 (47.2%) 82 (43.6%) 767 (46.6%)
DBP > 90
n (%)
38 (24.5%) 38 (8.3%) 82 (11.1%) 38 (13.7%) 196 (12%) 29 (12.2%) 34 (13.4%) 104 (15.6%) 49 (16.2%) 25 (13.3%) 241 (14.6%)
Chol > 240
n (%)
28 (18.1%) 66 (14.5%) 156 (21.2%) 44 (15.8%) 294 (18.1%) 41 (17.3%) 36 (14.2%) 138 (20.7%) 50 (16.5%) 27 (14.4%) 292 (17.7%)
Tri > 200
n (%)
20 (12.9%) 65 (14.2%) 80 (10.9%) 46 (16.5%) 211 (13%) 48 (20.2%) 48 (19%) 78 (11.7%) 41 (13.5%) 28 (14.9%) 243 (14.7%)
Deprivation index
High
n (%)
142 (91.6%) 49 (10.7%) 140 (19%) 105 (37.8%) 436 (26.8%) 13 (5.5%) 32 (12.6%) 226 (34%) 133 (43.9%) 35 (18.6%) 439 (26.6%)
Medium
n (%)
9 (5.8%) 109 (23.9%) 219 (29.7%) 64 (23%) 401 (24.7%) 37 (15.5%) 65 (25.7%) 282 (42.4%) 96 (31.7%) 114 (60.6%) 594 (36.1%)
Low
n (%)
4 (2.6%) 298 (65.3%) 378 (51.3%) 109 (39.2%) 789 (48.5%) 188 (79%) 156 (61.7%) 157 (23.6%) 74 (24.4%) 39 (20.7%) 614 (37.3%)
Physical activity (PA)
A1_PA
n (%)
19 (12.3%) 46 (10.1%) 44 (6%) 31 (11.1%) 140 (9%) 25 (10.5%) 24 (9.5%) 41 (6.2%) 49 (16.2%) 47 (25%) 186 (11.3%)
A2_PA
n (%)
16 (10.3%) 28 (6.1%) 27 (3.7%) 25 (9%) 96 (5.9%) 21 (8.9%) 21 (8.2%) 23 (3.5%) 42 (13.9%) 42 (22.6%) 149 (9%)
A4_PA
n (%)
5 (3.2%) 5 (1.9%) 12 (1.6%) 5 (1.8%) 27 (1.7%) 7 (3.1%) 7 (2.8%) 3 (0.4%) 5 (1.6%) 6 (3.2%) 28 (1.7%)
Diet (DT)
A1_DT
n (%)
23 (14.8%) 66 (14.5%) 78 (10.6%) 33 (11.9%) 200 (12.3%) 35 (14.7%) 26 (10.3%) 70 (10.5%) 65 (21.4%) 53 (28.2%) 249 (15.1%)
A2_DT
n (%)
19 (12.3%) 52 (11.4%) 58 (7.9%) 27 (9.7%) 156 (9.6%) 29 (12.2%) 25 (9.9%) 48 (7.2%) 57 (18.8%) 43 (23.1%) 202 (12.3%)
A4_DT
n (%)
8 (5.2%) 28 (6.1%) 46 (6.2%) 15 (5.4%) 97 (6%) 12 (5.3%) 21 (8.3 %) 37 (5.6%) 37 (12.2%) 20 (10.6%) 127 (7.7%)
  1. Note: BMI, body mass index in kg/m2; Chol, cholesterol level in mg/dL; DBP, diastolic blood pressure in mmHg; SBP, systolic blood pressure in mmHg; Tri, triglyceride level in mg/dL